Atlas Trials

Stage IV Colon Cancer AJCC v8

18 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IV Colon Cancer AJCC v8

RecordFirmDate
Testing the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF Mutation (NCT05308446)National Cancer Institute (NCI)2022-07-19
Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery (NCT05296681)Howard S. Hochster, MD2022-05-03
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial (NCT04704661)National Cancer Institute (NCI)2021-08-09
Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events (NCT05038254)M.D. Anderson Cancer Center2021-05-12
18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases (NCT04752267)University of Southern California2021-02-15
LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer (NCT04616183)M.D. Anderson Cancer Center2020-12-02
SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial (NCT04599140)M.D. Anderson Cancer Center2020-10-14
Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer (NCT04362839)City of Hope Medical Center2020-05-27
Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer (NCT03992456)Academic and Community Cancer Research United2020-04-24
Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial (NCT03765736)Academic and Community Cancer Research United2020-04-20
TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study (NCT04109924)Roswell Park Cancer Institute2019-12-27
Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer (NCT03592641)National Cancer Institute (NCI)2019-07-25

Track Stage IV Colon Cancer AJCC v8 automatically

Every clearance here is in the API, with alerts when new ones post.